{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:23:32Z","timestamp":1794349412625,"version":"4.9.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013348","name":"Innosuisse Swiss Innovation Agency","doi-asserted-by":"publisher","award":["119.403 IP-LS"],"award-info":[{"award-number":["119.403 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.117521","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:12:32Z","timestamp":1789593152000},"page":"117521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV"],"prefix":"10.1016","volume":"29","author":[{"given":"Enja Tatjana","family":"Kipfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Otte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9950-365X","authenticated-orcid":false,"given":"David","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117521_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117521_bib2","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117521_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117521_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117521_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1473-3099(20)30942-7","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","volume":"21","author":"Ella","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.117521_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14760584.2021.1991794","article-title":"SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways","volume":"21","author":"Mekonnen","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2026.117521_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103699","article-title":"Current and future nanoparticle vaccines for COVID-19","volume":"74","author":"Vu","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.117521_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.873596","article-title":"The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis","volume":"10","author":"Rahmani","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.isci.2026.117521_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.117521_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae527","article-title":"Benefits of Repeated SARS-CoV-2 Vaccination and Virus-induced Cross-neutralization Potential in Immunocompromised Transplant Patients and Healthy Individuals","volume":"11","author":"Hauser","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.isci.2026.117521_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/vaccines12121345","article-title":"Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions","volume":"12","author":"Hsiung","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2026.117521_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41541-023-00753-4","article-title":"A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity","volume":"8","author":"Adam","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2026.117521_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101347","article-title":"Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine","volume":"62","author":"Yeung","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70864-8","article-title":"Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome","volume":"10","author":"Crooke","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117521_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117521_bib16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117521_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02209-20","article-title":"Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes","volume":"95","author":"Chiem","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02379-22","article-title":"Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus","volume":"10","author":"Chiem","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.117521_bib19","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1128\/JVI.77.21.11312-11323.2003","article-title":"Coronaviruses as vectors: position dependence of foreign gene expression","volume":"77","author":"de Haan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib20","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1128\/JVI.79.20.12742-12751.2005","article-title":"Coronaviruses as vectors: stability of foreign gene expression","volume":"79","author":"de Haan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117521_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An Infectious cDNA Clone of SARS-CoV-2","volume":"27","author":"Xie","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.117521_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx7487","article-title":"Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV","volume":"11","author":"Xu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.117521_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111593118","article-title":"Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses","volume":"118","author":"Ye","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.isci.2026.117521_bib25","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3201\/eid2609.201495","article-title":"Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2","volume":"26","author":"Banerjee","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2026.117521_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/rna.8.2.15013","article-title":"Coronaviruses: An RNA proofreading machine regulates replication fidelity and diversity","volume":"8","author":"Denison","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.isci.2026.117521_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117521_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2008.03.002","article-title":"SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector","volume":"376","author":"Kapadia","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.isci.2026.117521_bib29","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2021.12.063","article-title":"Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine","volume":"40","author":"Peng","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.117521_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41541-022-00508-7","article-title":"Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2","volume":"7","author":"Taddeo","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2026.117521_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.117521_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104138","article-title":"Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial","volume":"82","author":"Robbins","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.117521_bib33","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","article-title":"A single dose of recombinant VSV-\u0394G-spike vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Yahalom-Ronen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117521_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03379-21","article-title":"Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine","volume":"13","author":"Furuyama","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.117521_bib35","article-title":"One and Done: A safe, adaptable single-cycle SARS-CoV-2 vaccine platform blocks XBB.1.5 infection and transmission","author":"Sch\u00f6n","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117521_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41541-024-00992-z","article-title":"High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters","volume":"9","author":"Lett","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2026.117521_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89035","article-title":"Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform","volume":"12","author":"Kipfer","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.117521_bib38","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.isci.2026.117521_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf133","article-title":"Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery","volume":"53","author":"Yang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.117521_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01837-21","article-title":"Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories","volume":"96","author":"Malicoat","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/biom15020280","article-title":"Sequences in the Cytoplasmic Tail Contribute to the Intracellular Trafficking and the Cell Surface Localization of SARS-CoV-2 Spike Protein","volume":"15","author":"Burkova","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2026.117521_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.117521_bib43","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117521_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02372-18","article-title":"Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors","volume":"10","author":"Slough","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.117521_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq4545","article-title":"Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus","volume":"11","author":"Adeleke","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.117521_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41580-022-00524-4","article-title":"Regulation of membrane protein structure and function by their lipid nano-environment","volume":"24","author":"Levental","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.117521_bib47","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41467-020-19891-7","article-title":"Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice","volume":"11","author":"Oladunni","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117521_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48397-7","article-title":"Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both","volume":"13","author":"Beitari","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117521_bib49","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1038\/s41467-025-59533-4","article-title":"SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform","volume":"16","author":"Kuroda","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117521_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104203","article-title":"Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera","volume":"82","author":"Espeseth","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.117521_bib51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2100421","article-title":"Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity","volume":"207","author":"Matchett","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117521_bib52","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated Vesicular Stomatitis Viruses as Vaccine Vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117521_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1074-7613(00)80277-0","article-title":"The Role of Somatic Mutation in the Generation of the Protective Humoral Immune Response against Vesicular Stomatitis Virus","volume":"5","author":"Kalinke","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.117521_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virusres.2006.07.005","article-title":"Antigenic and cellular localisation analysis of the severe acute respiratory syndrome coronavirus nucleocapsid protein using monoclonal antibodies","volume":"122","author":"Bussmann","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.isci.2026.117521_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001091","article-title":"A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research","volume":"19","author":"Rihn","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.isci.2026.117521_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s42003-022-03427-4","article-title":"SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication","volume":"5","author":"Miyamoto","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2026.117521_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV GenomePromoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.117521_bib59","series-title":"Molecular Assays to Diagnose COVID-19: Summary Table of Available Protocols","year":"2020"},{"key":"10.1016\/j.isci.2026.117521_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.isci.2026.117521_bib61","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: pairwise alignment for nucleotide sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.117521_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.isci.2026.117521_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13059-020-02107-y","article-title":"Long-read-based human genomic structural variation detection with cuteSV","volume":"21","author":"Jiang","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.117521_bib64","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.117521_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117521_bib66","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/tbed.13926","article-title":"Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals","volume":"68","author":"Wernike","year":"2021","journal-title":"Transbound. Emerg. Dis."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:40:20Z","timestamp":1794346820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226029007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226029007"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117521","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117521"}}